Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with oral thalidomide
نویسندگان
چکیده
منابع مشابه
Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case.
BACKGROUND Necrobiosis lipoidica diabeticorum (NLD) is a rare, granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus. Skin lesions usually develop on the lower extremities and can progress toward ulceration and scarring. Many treatments have been proposed, but few have demonstrated consistent efficacy, and no standard regimens have emerged to dat...
متن کاملNecrobiosis Lipoidica Diabeticorum
INTRODUCTION Necrobiosis lipoidica (NL) is a rare chronic granulomatous dermatitis that usually appears in the lower extremities. It affects about 0.3-1.2% of diabetic patients, the majority of whom have type 1 diabetes. The etiology and pathogenesis of this disorder are still unclear. NL is characterized by skin rash that usually affects the shins. The average onset is 30 years, with females b...
متن کاملNecrobiosis lipoidica diabeticorum.
Necrobiosis lipoidica diabeticorum ("NLD") is a rash that occurs on the lower legs. It is more common in women, as seen in our case and there are usually several spots. They are slightly raised shiny red-brown patches. The centers are often yellowish and may develop open sores that are slow to heal. Often a biopsy is needed to diagnose NLD.NLD usually occurs more often in people with diabetes, ...
متن کاملNecrobiosis Lipoidica Diabeticorum
Necrobiosis lipoidica is a rare disorder that usually appears in the lower extremities and it is often related to diabetes mellitus. There are few reported cases of necrobiosis lipoidica in children. We present an interesting case in that the patient developed lesions on the abdomen, which is an unusual location.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Dermatology Online Journal
سال: 2016
ISSN: 2229-5178
DOI: 10.4103/2229-5178.174328